510(k) K233605

ADVIA Centaur EBV-EBNA IgG by Biokit, S.A. — Product Code LLM

K233605 is an FDA 510(k) premarket notification submitted by Biokit, S.A. for the device "ADVIA Centaur EBV-EBNA IgG". The FDA issued a decision of Substantially Equivalent on Aug 7, 2024. The device falls under product code LLM (Test, Antigen, Nuclear, Epstein-Barr Virus), a Class I device regulated under 21 CFR 866.3235. Biokit, S.A. has 22 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 7, 2024
Date Received
Nov 9, 2023
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Test, Antigen, Nuclear, Epstein-Barr Virus
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type
510(k)

Need the full FDA record for Biokit, S.A.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K233605. Report a data issue: hello@regdatalab.com.